Corporate Banner
Satellite Banner
RNAi
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Stem Cell Symposium to Address Brain, Nervous System

Published: Thursday, April 12, 2012
Last Updated: Wednesday, April 11, 2012
Bookmark and Share
Seventh Symposium will focus on the mechanisms of neural development, modeling neural disorders, and harnessing the potential of neural regeneration.

Scientific leaders in the use of stem cells to solve scientific and medical problems will gather Wednesday, April 11 at the BioPharmaceutical Technology Center Institute in Fitchburg, just south of Madison.

The seventh annual Wisconsin Stem Cell Symposium - "Neural Stem Cells: Generation and Regeneration" - will focus on the mechanisms of neural development, modeling neural disorders, and harnessing the potential of neural regeneration.

Thirteen years after the isolation of human embryonic stem cells, scientists continue to explore them, and the related induced pluripotent stem cells (iPS cells), for medicine and basic research.

The symposium will focus on a key potential for stem cells - studying, even repairing, the brain and other parts of the nervous system. Topics include:

• What are the key mechanisms that underlie neural development?

• How are stem cells being used to model development and disease?

• How can we manipulate the "niche" in which neural stem cells grow to influence their development?

The meeting will attract some major names in stem-cell biology, including:

• Rudolf Jaenisch (Massachusetts Institute of Technology) will discuss new methods for reprogramming stem cells;

• David Gamm (assistant professor of ophthalmology and visual sciences, UW-Madison School of Medicine and Public Health) will focus on using iPS cells to model human retinal disease;

• Yoshiki Sasai (RIKEN Center for Developmental Biology, Japan) will discuss molecular and cellular mechanisms that control neural differentiation and 3-D structure in pluripotent cells; and

• Xinyu Zhao (visiting associate professor of neuroscience at UW-Madison) will describe how RNA controls the development of stem cells into neural structures.

The symposium is co-sponsored by the University of Wisconsin Stem Cell Regenerative Medicine Center and the BioPharmaceutical Technology Center Institute. PeproTech and Promega Corporation are serving as Platinum Sponsors.

BTC Institute provides educational opportunities to support scientific understanding and contribute to the continued success of the biotechnology industry.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,400+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Petri Dish Tumor Test
In a highly successful, first-of-its-kind endeavour, researchers have created a "tumor in a dish:" an ex vivo microenvironment that can accurately anticipate a multiple myeloma patient's response to a drug.
Monday, June 15, 2015
Wisconsin Scientists Find Genetic Recipe to Turn Stem Cells to Blood
The ability to reliably and safely make in the laboratory all of the different types of cells in human blood is one key step closer to reality.
Monday, July 14, 2014
Study Reveals Critical Similarity Between Two Types of Do-it-All Stem Cells
Researchers at the University of Wisconsin-Madison report the first full measurement of the proteins made by both types of stem cells.
Monday, September 12, 2011
Study Shows Patient’s Own Cells may Hold Therapeutic Promise After Reprogramming, Gene Correction
Scientists determine that the process of correcting a genetic defect does not substantially increase the number of potentially cancer-causing mutations in induced pluripotent stem cells.
Wednesday, April 13, 2011
Scientific News
Detection of HPV in First-Void Urine
Similar sensitivity of HPV test on first void urine sample compared to cervical smear.
Potential “Good Fat” Biomarker
New method to measure the activity of energy consuming brown fat cells could ease the testing weight loss drugs.
Shape Of Tumor May Affect Whether Cells Can Metastasize
Illinois researchers found that the shape of a tumor may play a role in how cancer cells become primed to spread.
MicroRNA Pathway Could Lead to New Avenues for Leukemia Treatment
Cancer researchers at the University of Cincinnati have found a particular signaling route in microRNA (miR-22) that could lead to targets for acute myeloid leukemia, the most common type of fast-growing cancer of the blood and bone marrow.
Analysis of Dog Genome will Provide Insight into Human Disease
An important model in studying human disease, the non-coding RNA of the canine genome is an essential starting point for evolutionary and biomedical studies – according to a new study led by The Genome Analysis Centre (TGAC).
New Blood Test for The Earlier Diagnosis of Breast Cancer Spread
Researchers at University of Westminster have confirmed that a new blood test can detect if breast cancer has spread to other parts of the body.
First Gene Therapy Successful Against Human Aging
American woman gets biologically younger after gene therapies.
Targeting an ‘Undruggable’ Cancer Gene
RAS genes are mutated in more than 30 percent of human cancers and represent one of the most sought-after cancer targets for drug developers.
Altered Metabolism of Four Compounds Drives Glioblastoma Growth
Findings suggest new ways to treat the malignancy, slow its progression and reveal its extent more precisely.
Improving Engineered T-Cell Cancer Treatment
Purdue University researchers may have figured out a way to call off a cancer cell assassin that sometimes goes rogue and assign it a larger tumor-specific "hit list."
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,400+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!